医薬品・医療機器も外資規制強化　コロナ長期戦へ７月適用―改正外為法

　政府は１５日、改正外為法で外国人投資家への事前審査を厳格化する対象に、医薬品と、人工呼吸器などの高度医療機器を追加したと発表した。新型コロナウイルスとの長期戦をにらんで、高度機器を製造できる国内メーカーが中国勢などに買収される事態を阻止し、国内の安定供給を図る。７月１５日から適用する。
　改正外為法に基づく安全保障上の重要業種として、「感染症に対する医薬品」と「高度管理医療機器」を手掛ける製造業を指定。こうした国内企業の株式を外国人が取得する場合、出資比率「１％以上」のケースで政府への事前届け出が必要となる。製薬会社も対象となる見込みだ。（2020/06/15-16:59）

The Japanese government said Monday that it will toughen regulations on foreign investment in domestic makers of drugs for infectious diseases and advanced medical equipment including ventilators.
   The move is aimed at preventing domestic medical manufacturers from being acquired by Chinese or other foreign entities and ensuring stable domestic supplies of medical products, with the fight against the COVID-19 epidemic expected to be prolonged.
   The government announced its decision to add the medical makers to the list of national security-linked firms under the revised foreign exchange and trade law. The change will be effective from July 15.
   The revised law, put into force on June 7, requires advance notice to the government of the acquisition by foreigners of an equity stake of one pct or more in any of the domestic companies on the list.
   A total of 558 companies in 12 fields including weapons, aircraft, space, nuclear energy, communications and railways are currently on the list.